NCT01587040 2022-04-19
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Sanofi
Phase 1/2 Completed
Clinical Trials
3 trialsNCT01042925 2016-06-03
Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen
Sanofi
Phase 1/2 Completed
NCT01082068 2016-06-03
Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer
Sanofi
Phase 1/2 Completed